Modified External Oblique Intercostal Plane Block Versus Erector Spinae Plane Block for Open Nephrectomy
EOIPB-ON
Comparison of Modified External Oblique Intercostal Plane Block and Erector Spinae Plane Block for Postoperative Analgesia in Patients Undergoing Open Nephrectomy: A Prospective Randomized Controlled Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
This prospective, randomized, assessor-blinded clinical trial aims to compare the postoperative analgesic efficacy of ultrasound-guided Erector Spinae Plane Block (ESPB) and Modified External Oblique Intercostal Plane Block (EOIPB) in patients undergoing elective open nephrectomy under general anesthesia. Sixty adult patients will be randomized to receive either ESPB or EOIPB before surgical incision. All participants will receive standardized general anesthesia and postoperative multimodal analgesia. Postoperative pain scores, opioid consumption, rescue analgesic requirements, and postoperative nausea and vomiting will be assessed during the first 24 hours after surgery. The study aims to determine whether one fascial plane block technique provides superior postoperative pain control and recovery following open nephrectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable postoperative-pain
Started Aug 2026
Shorter than P25 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2026
CompletedFirst Posted
Study publicly available on registry
July 24, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
July 24, 2026
July 1, 2026
6 months
June 22, 2026
July 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain intensity at rest
Postoperative pain intensity will be assessed at rest using the 11-point Numeric Rating Scale, ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
0, 2, 6, 12, and 24 hours after surgery
Secondary Outcomes (6)
Pain intensity during movement
0, 2, 6, 12, and 24 hours after surgery
Total Opioid Consumption
24 hours after surgery
Rescue Analgesic Requirement
24 hours after surgery
Postoperative Nausea and Vomiting
24 hours after surgery
Heart Rate
From induction of anesthesia until the end of surgery
- +1 more secondary outcomes
Study Arms (2)
ESPB Group
EXPERIMENTALParticipants will receive an ultrasound-guided erector spinae plane block with 30 mL of 0.25% bupivacaine after induction of general anesthesia and before surgical incision. Standardized general anesthesia and postoperative multimodal analgesia will be provided to all participants.
EOIPB Group
EXPERIMENTALParticipants will receive an ultrasound-guided modified external oblique intercostal plane block with 30 mL of 0.25% bupivacaine after induction of general anesthesia and before surgical incision. Standardized general anesthesia and postoperative multimodal analgesia will be provided to all participants.
Interventions
Ultrasound-guided modified external oblique intercostal plane block performed after induction of general anesthesia using 30 mL of 0.25% bupivacaine before surgical incision.
Ultrasound-guided erector spinae plane block performed after induction of general anesthesia using 30 mL of 0.25% bupivacaine before surgical incision.
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years.
- American Society of Anesthesiologists (ASA) physical status I or II.
- Scheduled for elective open nephrectomy.
- Able and willing to provide written informed consent.
- Willing to comply with study procedures.
You may not qualify if:
- Refusal to participate or inability to provide informed consent.
- Emergency surgery.
- Body mass index (BMI) greater than 35 kg/m².
- Known allergy or hypersensitivity to local anesthetics.
- Infection at the planned block insertion site.
- Coagulopathy or ongoing anticoagulant therapy.
- Pregnancy or breastfeeding.
- Prisoners or other vulnerable populations unable to provide independent consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tekirdağ Namık Kemal University
Tekirdağ, Tekirdağ, 59000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants will be unaware of group allocation because all block procedures will be performed after induction of general anesthesia. Postoperative outcome assessments will be conducted by a researcher who is blinded to treatment allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Anesthesiology and Reanimation
Study Record Dates
First Submitted
June 22, 2026
First Posted
July 24, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
July 24, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
De-identified individual participant data are not planned to be shared because no formal data-sharing infrastructure or approved data-sharing plan has been established for this study.